Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides (Q39761178)

14 September 2017

Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides (English)

1 reference

14 September 2017

5

Roger Y Tsien

1 reference

14 September 2017

Todd A Aguilera

1

1 reference

14 September 2017

Emilia S Olson

series ordinal

2

1 reference

14 September 2017

Margaret M Timmers

series ordinal

3

1 reference

14 September 2017

Tao Jiang

series ordinal

4

1 reference

14 September 2017

11 May 2009

1 reference

14 September 2017

1 reference

14 September 2017

1

1 reference

14 September 2017

5-6

1 reference

14 September 2017

371-381

1 reference

Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?".

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

In vivo protein transduction: delivery of a biologically active protein into the mouse

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

Is VP22 nuclear homing an artifact?

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796831

In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer

20 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1039%2FB904878B

Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20023744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Novel Tat-Peptide Chelates for Direct Transduction of Technetium-99m and Rhenium into Human Cells for Imaging and Radiotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20023744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A proapoptotic peptide for the treatment of solid tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20023744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1039/B904878B

1 reference

14 September 2017

1 reference

14 September 2017

1 reference